Suppr超能文献

肝硬化对因坏死性筋膜炎入院患者发病率和死亡率的影响。

Impact of liver cirrhosis on morbidity and mortality of patients admitted to the hospital with necrotizing fasciitis.

作者信息

El Labban Mohamad, Kotys Juliet, Makher Sabrina, Pannala Sai Shanmukha Sreeram, El Gharib Khalil, Chehab Hamed, Deeb Liliane, Surani Salim R

机构信息

Department of Internal Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.

Department of Internal Medicine, Staten Island University Hospital, New York, NY 10305, United States.

出版信息

World J Hepatol. 2025 Jan 27;17(1):102270. doi: 10.4254/wjh.v17.i1.102270.

Abstract

BACKGROUND

Necrotizing fasciitis (NF) is a potentially fatal bacterial infection of the soft tissues. Liver cirrhosis appears to be a contributing factor to higher morbidity and mortality in patients with NF. This research article explores the relationship between these two conditions.

AIM

To evaluate whether liver cirrhosis increases morbidity and mortality in patients with NF, focusing on inpatient mortality, septic shock, length of stay, and hospital costs.

METHODS

This retrospective cohort study utilized data from the Healthcare Cost and Utilization Project 2019 National Inpatient Sample. Cases were identified as patients with both NF and cirrhosis, while controls were non-cirrhotic. The study focused on inpatient mortality as the primary outcome, with secondary outcomes including surgical limb amputation, mechanical ventilation rates, septic shock, length of stay, and hospital costs.

RESULTS

A total of 14920 patients were admitted to the hospital for management of NF, of which 2.11% had liver cirrhosis. Inpatient mortality was higher in cirrhotic patients (9.5% 3%; adjusted odds ratio = 3.78; value = 0.02). Cirrhotic patients also had higher rates of septic shock (10.5% 4.9%, value < 0.01). Length of hospital stay, total charges, and rates of mechanical ventilation were not statistically different between groups.

CONCLUSION

Liver cirrhosis is an independent risk factor of in-hospital mortality and morbidity in patients with NF. Clinicians should be aware of this association to ensure better clinical outcomes and spare healthcare expenditure.

摘要

背景

坏死性筋膜炎(NF)是一种潜在致命的软组织细菌感染。肝硬化似乎是NF患者发病率和死亡率升高的一个促成因素。这篇研究文章探讨了这两种情况之间的关系。

目的

评估肝硬化是否会增加NF患者的发病率和死亡率,重点关注住院死亡率、感染性休克、住院时间和住院费用。

方法

这项回顾性队列研究利用了2019年医疗成本与利用项目全国住院样本的数据。病例被确定为同时患有NF和肝硬化的患者,而对照组为非肝硬化患者。该研究将住院死亡率作为主要结局,次要结局包括手术截肢、机械通气率、感染性休克、住院时间和住院费用。

结果

共有14920名患者因NF入院治疗,其中2.11%患有肝硬化。肝硬化患者的住院死亡率更高(9.5%对3%;调整后的优势比=3.78;P值=0.02)。肝硬化患者的感染性休克发生率也更高(10.5%对4.9%,P值<0.01)。两组之间的住院时间、总费用和机械通气率在统计学上没有差异。

结论

肝硬化是NF患者院内死亡率和发病率的独立危险因素。临床医生应意识到这种关联,以确保更好的临床结果并节省医疗支出。

相似文献

10
Outcomes of MitraClip Placement in Patients With Liver Cirrhosis.经导管二尖瓣夹合术治疗肝硬化患者的疗效。
Cardiovasc Revasc Med. 2021 Aug;29:50-53. doi: 10.1016/j.carrev.2020.08.014. Epub 2020 Aug 12.

引用本文的文献

本文引用的文献

2
Infections in cirrhosis.肝硬化中的感染。
Lancet Gastroenterol Hepatol. 2024 Aug;9(8):745-757. doi: 10.1016/S2468-1253(24)00078-5. Epub 2024 May 13.
3
Cirrhosis-associated immune dysfunction.肝硬化相关免疫功能障碍。
Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):112-134. doi: 10.1038/s41575-021-00520-7. Epub 2021 Oct 26.
5
Necrotizing Soft-Tissue Infections.坏死性软组织感染
N Engl J Med. 2017 Dec 7;377(23):2253-2265. doi: 10.1056/NEJMra1600673.
7
Necrotizing fasciitis: risk factors of mortality.坏死性筋膜炎:死亡风险因素
Risk Manag Healthc Policy. 2015 Feb 16;8:1-7. doi: 10.2147/RMHP.S77691. eCollection 2015.
8
Current concepts in the management of necrotizing fasciitis.坏死性筋膜炎治疗的当前概念
Front Surg. 2014 Sep 29;1:36. doi: 10.3389/fsurg.2014.00036. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验